Drugs / Standard dose trivalent inactivated influenza vaccine
Standard dose trivalent inactivated influenza vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01525004 Comparator | Sep 2011 → Jun 2012 | disease related to solid organ transplantation | Vanderbilt University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Standard dose trivalent inactivated influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01525004 ↗ |
| Modality | Vaccine | “standard dose trivalent inactivated influenza vaccine” NCT01525004 ↗ |
| Route | Intramuscular | “HD (60 μg) or SD (15 μg) TIV intramuscularly” NCT01525004 ↗ |